Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386593102> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W4386593102 abstract "Background and Objective: Disease relapse and therapy resistance remain serious impediments to treating cancer. Leukemia stem cells (LSC) are therapy resistant and the cause of relapse. A state of deep quiescence appears to enable cancer stem cells (CSC) to acquire new somatic mutations essential for disease progression and therapy resistance. Both normal hematopoietic stem cells (HSC) and LSC share many common features, thereby complicating the safe elimination of LSC. A recent study demonstrated that long lived normal oocytes exist without mitochondrial complex I (MC-1), expressing it in a developmentally regulated fashion, thereby mitigating their vulnerability to ROS. Quiescent CSC rely on mitochondrial FAO, without complex I expression, thereby avoiding the generation of damaging ROS, similar to long lived normal human stem cells. A deeper understanding of the biology of therapy resistance is important for the development of optimal strategies to attain complete leukemia cures. Methods: Here, using scRNA-sequencing and ATAC-seq on primary chronic myelogenous leukemia (CML) patient samples, combined with bioinformatics analyses, we further examine the heterogeneity of a previously characterized in vitro imatinib-selected CD34-CD38- CML LSC population. We utilized a series of functional analyses, including single-cell metabolomic and Seahorse analyses, to validate the existence of the deepest quiescent leukemia initiators (LI) subset. Results: Current study revealed heterogeneity of therapy resistant LSC in CML patients and their existence of two functionally distinct states. The most deeply quiescent LI suppress the expression of MC-1, yet are highly dependent on fatty acid oxidation (FAO) for their metabolic requirements and ATAC-seq demonstrated increased chromatin accessibility in this population, all consistent with an extremely primitive, quiescent stemness transcriptional signature. Importantly, the specific CREB binding protein (CBP)/β-catenin antagonist ICG-001 initiates the differentiation of LSC, including LI, decreases chromatin accessibility with differentiation and increasing expression of MC-1, CD34, CD38 and BCR-ABL1, thereby re-sensitizing them to imatinib. Conclusion: We investigated the biological aspects related to LSC heterogeneity in CML patients and demonstrated the ability of specific small molecule CBP/β-catenin antagonists to safely eliminate deeply quiescent therapy resistant CSC. These observations may represent an attractive generalizable therapeutic strategy that could help develop better protocols to eradicate the quiescent LSC population." @default.
- W4386593102 created "2023-09-12" @default.
- W4386593102 creator A5007870197 @default.
- W4386593102 creator A5015303746 @default.
- W4386593102 creator A5018798767 @default.
- W4386593102 creator A5021085703 @default.
- W4386593102 creator A5030303113 @default.
- W4386593102 creator A5030981930 @default.
- W4386593102 creator A5036411451 @default.
- W4386593102 creator A5038145161 @default.
- W4386593102 creator A5039259069 @default.
- W4386593102 creator A5042664422 @default.
- W4386593102 creator A5045364810 @default.
- W4386593102 creator A5059671180 @default.
- W4386593102 creator A5065325837 @default.
- W4386593102 creator A5066355670 @default.
- W4386593102 creator A5076318169 @default.
- W4386593102 creator A5077911941 @default.
- W4386593102 date "2023-10-02" @default.
- W4386593102 modified "2023-10-12" @default.
- W4386593102 title "A Deeply Quiescent Subset of CML LSC Depend on FAO Yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex I" @default.
- W4386593102 doi "https://doi.org/10.2174/1874467217666230906092236" @default.
- W4386593102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37691195" @default.
- W4386593102 hasPublicationYear "2023" @default.
- W4386593102 type Work @default.
- W4386593102 citedByCount "0" @default.
- W4386593102 crossrefType "journal-article" @default.
- W4386593102 hasAuthorship W4386593102A5007870197 @default.
- W4386593102 hasAuthorship W4386593102A5015303746 @default.
- W4386593102 hasAuthorship W4386593102A5018798767 @default.
- W4386593102 hasAuthorship W4386593102A5021085703 @default.
- W4386593102 hasAuthorship W4386593102A5030303113 @default.
- W4386593102 hasAuthorship W4386593102A5030981930 @default.
- W4386593102 hasAuthorship W4386593102A5036411451 @default.
- W4386593102 hasAuthorship W4386593102A5038145161 @default.
- W4386593102 hasAuthorship W4386593102A5039259069 @default.
- W4386593102 hasAuthorship W4386593102A5042664422 @default.
- W4386593102 hasAuthorship W4386593102A5045364810 @default.
- W4386593102 hasAuthorship W4386593102A5059671180 @default.
- W4386593102 hasAuthorship W4386593102A5065325837 @default.
- W4386593102 hasAuthorship W4386593102A5066355670 @default.
- W4386593102 hasAuthorship W4386593102A5076318169 @default.
- W4386593102 hasAuthorship W4386593102A5077911941 @default.
- W4386593102 hasBestOaLocation W43865931021 @default.
- W4386593102 hasConcept C10205521 @default.
- W4386593102 hasConcept C109159458 @default.
- W4386593102 hasConcept C121608353 @default.
- W4386593102 hasConcept C203014093 @default.
- W4386593102 hasConcept C2776960273 @default.
- W4386593102 hasConcept C2778461978 @default.
- W4386593102 hasConcept C28328180 @default.
- W4386593102 hasConcept C28859421 @default.
- W4386593102 hasConcept C2908647359 @default.
- W4386593102 hasConcept C502942594 @default.
- W4386593102 hasConcept C54355233 @default.
- W4386593102 hasConcept C55427017 @default.
- W4386593102 hasConcept C71924100 @default.
- W4386593102 hasConcept C86803240 @default.
- W4386593102 hasConcept C95444343 @default.
- W4386593102 hasConcept C96232424 @default.
- W4386593102 hasConcept C99454951 @default.
- W4386593102 hasConceptScore W4386593102C10205521 @default.
- W4386593102 hasConceptScore W4386593102C109159458 @default.
- W4386593102 hasConceptScore W4386593102C121608353 @default.
- W4386593102 hasConceptScore W4386593102C203014093 @default.
- W4386593102 hasConceptScore W4386593102C2776960273 @default.
- W4386593102 hasConceptScore W4386593102C2778461978 @default.
- W4386593102 hasConceptScore W4386593102C28328180 @default.
- W4386593102 hasConceptScore W4386593102C28859421 @default.
- W4386593102 hasConceptScore W4386593102C2908647359 @default.
- W4386593102 hasConceptScore W4386593102C502942594 @default.
- W4386593102 hasConceptScore W4386593102C54355233 @default.
- W4386593102 hasConceptScore W4386593102C55427017 @default.
- W4386593102 hasConceptScore W4386593102C71924100 @default.
- W4386593102 hasConceptScore W4386593102C86803240 @default.
- W4386593102 hasConceptScore W4386593102C95444343 @default.
- W4386593102 hasConceptScore W4386593102C96232424 @default.
- W4386593102 hasConceptScore W4386593102C99454951 @default.
- W4386593102 hasFunder F4320310408 @default.
- W4386593102 hasFunder F4320313589 @default.
- W4386593102 hasLocation W43865931021 @default.
- W4386593102 hasLocation W43865931022 @default.
- W4386593102 hasOpenAccess W4386593102 @default.
- W4386593102 hasPrimaryLocation W43865931021 @default.
- W4386593102 hasRelatedWork W1995874739 @default.
- W4386593102 hasRelatedWork W2044496404 @default.
- W4386593102 hasRelatedWork W2076802652 @default.
- W4386593102 hasRelatedWork W2079838338 @default.
- W4386593102 hasRelatedWork W2394047154 @default.
- W4386593102 hasRelatedWork W2396378578 @default.
- W4386593102 hasRelatedWork W2465944080 @default.
- W4386593102 hasRelatedWork W25899969 @default.
- W4386593102 hasRelatedWork W3195146630 @default.
- W4386593102 hasRelatedWork W4220735543 @default.
- W4386593102 hasVolume "17" @default.
- W4386593102 isParatext "false" @default.
- W4386593102 isRetracted "false" @default.
- W4386593102 workType "article" @default.